Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07202065) titled 'Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Dosing Immunoglobulin (Dose Ig)' on Sept. 24.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Monash University
Condition:
Myeloma
Non Hodgkin'
s Lymphoma
Leukemia
Intervention:
Biological: Immune Globulin Intravenous
Recruitment Status: Recruiting
Phase: Phase 2/Phase 3
Date of First Enrollment: April 28, 2025
Target Sample Size: 900
Countries of Recruitment:
Australia
To know more, visit https:/...